Cancer IVD market set for $8bn in 2012
This article was originally published in Clinica
Executive Summary
The global market for in vitro diagnostic (IVD) testing in cancer alone is growing at almost 11% per year and is set to touch $8bn by the end of 2012. So says New York-based market research firm Kalorama Information, in its study, The Worldwide Market for Cancer Diagnostics (3rd Edition).